The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized multicenter phase Ib/II study to assess the safety and the immunological effect of chemoradiation therapy (CRT) in combination with pembrolizumab (anti-PD1) to CRT alone in patients with resectable or borderline resectable pancreatic cancer.
 
Matthew H. G. Katz
No Relationships to Disclose
 
Todd W. Bauer
Stock and Other Ownership Interests - iTi Health
Consulting or Advisory Role - HemoShear
Research Funding - Tau Therapeutics
 
Gauri R. Varadhachary
No Relationships to Disclose
 
Gina R. Petroni
No Relationships to Disclose
 
Timothy Bullock
No Relationships to Disclose
 
Craig L. Slingluff
No Relationships to Disclose
 
Osama E. Rahma
Consulting or Advisory Role - Bayer; Celgene; Merrimack
Research Funding - Merck